State Street
TNYA icon

State Street’s Tenaya Therapeutics TNYA Stock Holding History

State Street’s Portfolio TNYA Stock Details TNYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$524K Hold
708,721
– – ﹤0.01% 3573
2026
Q1 		$491K Buy
708,721
+262,900
+59% +$194K ﹤0.01% 3661
2025
Q4 		$317K Hold
445,821
– – ﹤0.01% 3795
2025
Q3 		$722K Buy
445,821
+236,000
+112% +$238K ﹤0.01% 3585
2025
Q2 		$128K Sell
209,821
-915,431
-81% -$466K ﹤0.01% 3932
2025
Q1 		$642K Buy
1,125,252
+22,160
+2% +$21.9K ﹤0.01% 3534
2024
Q4 		$1.58M Buy
1,103,092
+44,194
+4% +$99.1K ﹤0.01% 3385
2024
Q3 		$2.04M Buy
1,058,898
+9,506
+0.9% +$26.8K ﹤0.01% 3323
2024
Q2 		$3.25M Buy
1,049,392
+80,095
+8% +$331K ﹤0.01% 3107
2024
Q1 		$5.07M Buy
969,297
+50,075
+5% +$240K ﹤0.01% 2920
2023
Q4 		$2.98M Buy
919,222
+40,159
+5% +$86.7K ﹤0.01% 3170
2023
Q3 		$2.24M Buy
879,063
+56,865
+7% +$238K ﹤0.01% 3278
2023
Q2 		$4.83M Buy
822,198
+325,398
+65% +$1.89M ﹤0.01% 3014
2023
Q1 		$1.42M Buy
496,800
+69,708
+16% +$196K ﹤0.01% 3430
2022
Q4 		$858K Buy
427,092
+22,327
+6% +$54.5K ﹤0.01% 3596
2022
Q3 		$1.17M Buy
404,765
+14,343
+4% +$66.9K ﹤0.01% 3566
2022
Q2 		$2.2M Buy
390,422
+95,033
+32% +$769K ﹤0.01% 3446
2022
Q1 		$3.48M Buy
295,389
+80,318
+37% +$972K ﹤0.01% 3344
2021
Q4 		$4.08M Buy
215,071
+32,734
+18% +$713K ﹤0.01% 3339
2021
Q3 		$3.77M Buy
+182,337
New +$3.92M ﹤0.01% 3380

Other funds holding TNYA

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EAM
Empery Asset Management New York $86.5M AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
BGM
Burkehill Global Management New York $2.77B AUM 65.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street's TNYA Position: Q2 2026 in Review

State Street held its Tenaya Therapeutics (TNYA) position steady in Q2 2026 at 708,721 shares worth $524K. The position accounts for ﹤0.01% of the portfolio, ranked #3573.

State Street first reported a position in TNYA in Q3 2021 and has held it in 20 quarters since. The position peaked at $5.07M in Q1 2024. 101 funds tracked by Wall St. Rank hold TNYA as of Q2 2026.

  • State Street held 708,721 shares of Tenaya Therapeutics worth $524K as of Q2 2026.
  • State Street left its Tenaya Therapeutics share count unchanged in Q2 2026.
  • Tenaya Therapeutics made up ﹤0.01% of State Street's portfolio in Q2 2026, its #3573 holding.
  • State Street first reported a position in Tenaya Therapeutics in Q3 2021 and has held it in 20 quarters since.
  • State Street's Tenaya Therapeutics position peaked at $5.07M in Q1 2024.
  • 101 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q2 2026.

Based on State Street's 13F filing for Q2 2026, filed 7 Aug 2026.